Diffuse large B cell lymphoma: Outlook, stages, treatment
A modified prognostic model in patients with diffuse large B‑cell lymphoma treated with immunochemotherapy
Overall survival of patients with diffuse large B-cell lymphoma... | Download Scientific Diagram
Flowchart of the survival analysis of patients with diffuse large... | Download Scientific Diagram
Favourable outcomes for high-risk diffuse large B-cell lymphoma (IPI 3–5) treated with front-line R-CODOX-M/R-IVAC chemotherapy: results of a phase 2 UK NCRI trial - Annals of Oncology
Prephase rituximab/prednisone therapy and aging-related, proinflammatory cytokine milieu in older, vulnerable patients with newly diagnosed diffuse large B-cell lymphoma | Haematologica
Diffuse Large B-Cell Lymphoma Risk Score Calculator: A Tool To Accurately Predict Survival Risk And Improve Treatment Decisions
Gray Zone Lymphoma (GZL) with Features Intermediate between Classical Hodgkin Lymphoma (cHL) and Diffuse Large B-Cell Lymphoma (DLBCL): A Large Retrospective. - ppt download
The International Prognostic Index Is Associated with Outcomes in Diffuse Large B Cell Lymphoma after Chimeric Antigen Receptor T Cell Therapy - Transplantation and Cellular Therapy, Official Publication of the American Society
Relapsed/Refractory International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma - Maurer - 2021 - American Journal of Hematology - Wiley Online Library
Large B-Cell Lymphoma Types and Association With Therapy and Prognosis... | Download Table
Overall survival curves of patients with primary gastric diffuse large... | Download Scientific Diagram
Follicular Lymphoma International Prognostic Index (FLIPI). Online calculator | ClinCaseQuest
CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP | Journal of Clinical Oncology
International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect
Frontiers | Development and Validation of a Novel Risk Stratification Model for Cancer-Specific Survival in Diffuse Large B-Cell Lymphoma
Quantitative Radiomics Features in Diffuse Large B-Cell Lymphoma: Does Segmentation Method Matter? | Journal of Nuclear Medicine
R/R International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B
A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising from Follicular Lymphoma in Asian patients treated in the Rituximab Era | Scientific Reports
A new prognostic score for AIDS-related lymphomas in the rituximab-era | Haematologica
